↓ Skip to main content
What is this page? Embed badge

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
10 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
32 Mendeley
Summary X Dimensions citations

This page is provided by Altmetric.